Alyeska Investment Group
JNJ icon

Alyeska Investment Group’s Johnson & Johnson JNJ Stock Holding History

Alyeska Investment Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204M Sell
834,692
-103,697
-11% -$24.2M 0.58% 35
2025
Q4 		$194M Buy
938,389
+193,070
+26% +$38.2M 0.55% 32
2025
Q3 		$138M Buy
745,319
+202,778
+37% +$34.7M 0.42% 47
2025
Q2 		$82.9M Buy
542,541
+408,814
+306% +$62.8M 0.29% 96
2025
Q1 		$22.2M Sell
133,727
-700,342
-84% -$110M 0.09% 233
2024
Q4 		$121M Buy
834,069
+102,255
+14% +$15.8M 0.45% 50
2024
Q3 		$119M Buy
731,814
+305,786
+72% +$48.7M 0.61% 37
2024
Q2 		$62.3M Sell
426,028
-188,972
-31% -$28.1M 0.36% 93
2024
Q1 		$97.3M Buy
615,000
+235,000
+62% +$37.4M 0.6% 43
2023
Q4 		$59.6M Buy
+380,000
New +$58.3M 0.39% 80
2020
Q2 		– Sell
-14,398
Closed -$1.89M – 533
2020
Q1 		$1.89M Buy
14,398
+10,236
+246% +$1.45M 0.04% 263
2019
Q4 		$607K Sell
4,162
-252,664
-98% -$34.3M 0.01% 347
2019
Q3 		$33.2M Buy
+256,826
New +$33.8M 0.48% 72
2019
Q2 		– Sell
-2,990
Closed -$418K – 482
2019
Q1 		$418K Buy
+2,990
New +$401K 0.01% 351
2018
Q1 		– Sell
-300,324
Closed -$42M – 476
2017
Q4 		$42M Buy
300,324
+6,338
+2% +$883K 0.33% 98
2017
Q3 		$38.2M Buy
+293,986
New +$39M 0.29% 116
2017
Q1 		– Sell
-464,345
Closed -$53.5M – 523
2016
Q4 		$53.5M Buy
+464,345
New +$53.6M 0.44% 73
2016
Q3 		– Sell
-693,731
Closed -$84.2M – 496
2016
Q2 		$84.2M Buy
693,731
+43,663
+7% +$4.96M 0.79% 20
2016
Q1 		$70.3M Buy
650,068
+108,532
+20% +$11.2M 0.65% 39
2015
Q4 		$55.6M Buy
541,536
+495,930
+1,087% +$49.9M 0.59% 50
2015
Q3 		$4.26M Buy
+45,606
New +$4.41M 0.05% 262

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alyeska Investment Group's JNJ Position: Q1 2026 in Review

Alyeska Investment Group reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $24.2M and leaving 834,692 shares worth $204M. The position accounts for 0.58% of the portfolio, ranked #35.

Alyeska Investment Group first reported a position in JNJ in Q3 2015 and has held it in 21 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Alyeska Investment Group held 834,692 shares of Johnson & Johnson worth $204M as of Q1 2026.
  • Alyeska Investment Group sold 103,697 Johnson & Johnson shares in Q1 2026, an estimated $24.2M.
  • Johnson & Johnson made up 0.58% of Alyeska Investment Group's portfolio in Q1 2026, its #35 holding.
  • Alyeska Investment Group first reported a position in Johnson & Johnson in Q3 2015 and has held it in 21 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.